There are times to press our advantage in small-cap momentum stocks, and there are times to let the stop-loss rules reduce our exposure. Right now, I am comfortable letting cash accumulate.

We have some substantial winners among our remaining holdings. We also have seven exits to report this month, and I do not plan to replace those positions immediately. I still have too many concerns about broader market direction and the possibility of a momentum crash to rush that money back into stocks.

Sponsored Content

Eat well without any effort.

Getting the nutrition you deserve doesn’t need to take up all your time. CookUnity delivers fresh dishes handcrafted by award-winning chefs, ready to heat in minutes. Build a custom menu for your entire week, so you can spend your evenings on your terms—not scrubbing pans. Skip, pause, or change your plan size anytime.

Having an empty slot in the portfolio does not create an obligation to fill it. The market does not pay us for maintaining a full roster of recommendations. We need opportunities that justify putting capital at risk.

The updated spreadsheet contains 18 remaining positions. 10 show gains since purchase, while eight show losses. Those are the spreadsheet’s reported cumulative position returns, rather than returns for November alone. There is considerable strength among our leaders, but the results also show why we need to remain selective.

logo

This is the part that matters.

No publisher. No overhead. Four strategies built to beat the market.

Get Full Access

Premium members get:

  • Small-Cap Momentum Portfolio — beats the market 16 of the last 20 years
  • Equity REITs Portfolio — beat the S&P 500 by 10%+ annually since 1972
  • Small-Cap Deep Value Portfolio — Walter Schloss used this method to compound at 20% annually for 47 years
  • Alternative Fixed Income Portfolio — 10%+ yields, low drama
  • Weekly macro video — credit spreads, NFCI, and hard data. No noise, no politics.
  • Quarterly biotech watchlist — smart money tracking, insider buying, a decade of backtested data. A hitlist, not a portfolio.

Reply

Avatar

or to participate

More From Tim Melvin’s Flagship Report

View more
caret-right